title: Prolonged use of bevacizumab may cause extensive coronary artery thrombosis.
authors: Baskent University, School of Medicine, Department of Medical Oncology, Adana, Turkey.
authors: S
authors: S
authors: Muallaoglu
authors: U
authors: U
authors: Disel
authors: A
authors: A
authors: Tekin
authors: H
authors: H
authors: Mertsoylu
authors: H
authors: H
authors: Abali
authors: O
authors: O
authors: Ozyilkan
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000068258:Bevacizumab; D003328:Coronary Thrombosis / Q000139:chemically induced*; D006801:Humans; D008297:Male
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab